State-level disparities in cervical cancer prevention and outcomes in the United States: a modeling study
Targeting an HPV vaccination coverage of 80% by 2030 will disproportionately benefit states with low coverage and higher cervical cancer incidence. Geographically focused analyses can better inform priorities.
Authors
- Karen Canfell (ORCID: https://orcid.org/0000-0002-6443-6618)
- Marina E. Wolf (ORCID: https://orcid.org/0000-0001-9129-3432)
- Ruanne V. Barnabas (ORCID: https://orcid.org/0000-0002-1793-6003)
- Caleb Easterly (ORCID: https://orcid.org/0000-0001-7853-377X)
- Ran Zhao (ORCID: https://orcid.org/0000-0001-9539-8274)
- Jane J Kim
- Valeria Gracia (ORCID: https://orcid.org/0000-0003-4853-2922)
- Shalini Kulasingam
- Fernando Alarid‐Escudero (ORCID: https://orcid.org/0000-0001-5076-1172)
- Inge M.C.M. de Kok (ORCID: https://orcid.org/0000-0002-9419-0452)
Institutions
- University of North Carolina at Chapel Hill (US)
- The University of Sydney (AU)
- University of Minnesota (US)
- Harvard University (US)
- Erasmus MC (NL)
- Massachusetts General Hospital (US)
- Management Sciences for Health (US)
- Stanford Health Care (US)
- University of Minnesota Medical Center (US)
- Minnesota Department of Health (US)
- Erasmus University Rotterdam (NL)
- Cancer Council NSW (AU)
- Stanford University (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1093/jnci/djae298
- Citations
- 2
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- National Institutes of Health
- National Cancer Institute